With enormous sums of capital managed in the UK, its managers seek optimal scientific-based investments to not only progress health […]
Thanks to an $3.75 million grant injection from the Cancer Institute, NSW Translational Program, researchers and clinicians from UNSW and […]
Moderna Inc. (Nasdaq: MRNA), the biotechnology company with one of the authorized vaccines for COVID-19, completed the manufacturing of clinical […]
Individuals from SoftBank Group Corp frequent the TrialSite News website on a daily basis. Clearly, there are individuals interested in the […]
The contract research organization (CRO), critically important in the world of drug development and clinical trials, represents a near $64 […]
Axis Spine Technologies Ltd (AST) has raised £2.2m in a funding round led by ACF Investors, with follow-on investment from Mercia’s EIS […]
Centessa Pharmaceuticals (“Centessa”) launched today as a novel asset-centric pharmaceutical company designed and built to advance a portfolio of highly […]
Two patients with sickle cell disease involved with a gene-based therapy trial now have been diagnosed with cancer, and the […]
Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating cancer and neurodegenerative disease through the […]
The government of South Korea plans on allocating $237.1 million (262.7 billion won) to support local biotech companies and their […]
